12:00 AM
Oct 01, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Tradjenta regulatory update

EMA's CHMP issued a positive opinion to expand the indication of Trajenta linagliptin to include add-on therapy to insulin with or without metformin to treat Type II diabetes. Boehringer and partner...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >